By the year 2025, more than 300 million adults will have diabetes, with most of the increase occurring in the developing world (World Health Organization).
San Diego State University researchers, as well as representatives from San Diego’s health care and pharmaceutical communities, will present current research, treatment and outreach at the Global Diabetes Epidemic Symposium on Thursday, April 29.
The symposium begins at 1:30 p.m. in the Parma Payne Goodall Alumni Center on the corner of 55th Street and Hardy Avenue.
The keynote speaker is Ann Albright, director of the Division of Diabetes Translation at the Centers for Disease Control and Prevention.
Additional guest speakers include:
- Dr. Matthew Wintle, director of R&D Strategic Relations, Amylin Pharmaceuticals
- Chris Walker, MPH, director of Public Health Programs, Scripps Whittier Diabetes Institute
SDSU Graduate School of Public Health speakers include:
- Dr. Thomas E. Novotny, MPH, associate director for Border and Global Health will discuss the global burden of diabetes
- Guadalupe Xochitl Ayala will discuss her current research on the diabetes epidemic among Latinos
- Dr. Greg Talavera, MPH, will discuss diabetes at the border
About the symposium
The symposium will begin with student poster sessions at 1:30 p.m., followed by speakers from 2 - 5 p.m. and a closing reception from 5 - 6 p.m. Free parking is available in PS5 on 55th Street, next to the PPG Alumni Center.
Reserve your seat
The event is free and open to the public, but reservations are requested. Register for the event at http://sdsualumni.org/diabetessymposium.